Category Archives : Allgemein

Home  >>  Allgemein

TRANSVAC: European Vaccine Research and Development Infrastructure

On Oktober 17, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für TRANSVAC: European Vaccine Research and Development Infrastructure

TRANSVAC is a new infrastructure project – funded by the European Commission in the context of Horizon 2020 – that aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal  to build an efficient and sustainable collaboration of experts…

Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups

On Oktober 12, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups

Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups International Biotech Semifinal of the European Health Catapult Heidelberg, 12 October 2017 On October 4-6, BioRN, together with EIT Health, organized the Biotech Semifinal of the European Health Catapult. The Biotech semifinal consisted of two training days…

EMBL: Looping the loops: How chromosomes form

On Oktober 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: Looping the loops: How chromosomes form

EMBL researchers and collaborators take important steps in unravelling chromosome formation The nucleus of a human cell is less than one hundredth of a millimetre across but the DNA inside it – if stretched out – would be around two metres long. To fit into such a small space, the…

Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes

On Oktober 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes

Orphan designations facilitate the development and authorization of medicines for rare diseases, as assessed by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products  Heidelberg, Germany, October 05, 2017 – Apogenix AG, a biopharmaceutical company developing next-generation immuno-oncology therapeutics, announced today that its lead product candidate, asunercept (APG101), has…

PROGEN acquires EuroProxima’s research antibodies

On Oktober 9, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für PROGEN acquires EuroProxima’s research antibodies

PROGEN Biotechnik GmbH expands portfolio in the cell biology market Heidelberg, 05.10.2017 – PROGEN Biotechnik GmbH, established manufacturer of premium antibodies, has recently acquired the research antibody line of the Dutch company EuroProxima B.V., a global provider of immunobiological test systems. The deal encompasses about 190 products that supplement PROGEN’s…

Roche: Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams

On Oktober 3, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Roche: Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams

Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams The NAVIFY Tumor Board solution is a new, cloud-based software solution that fundamentally changes the way oncology care teams prepare for, conduct and document clinical treatment decisions for cancer patients It supports care team collaboration and…

DKFZ: Endowed chair at the German Cancer Research Centre commences work thanks to a one-million Euro donation from CTS EVENTIM

On Oktober 3, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: Endowed chair at the German Cancer Research Centre commences work thanks to a one-million Euro donation from CTS EVENTIM

The German Cancer Research Centre (Deutsches Krebsforschungszentrum, DKFZ) has created an endowed Chair in Chromatin Networks with the University of Heidelberg. Karsten Rippe, a biophysicist, will take up the Chair and will lead this department of the DKFZ. The new professorship is funded by CTS EVENTIM, one of the world’s…

DKFZ researcher is among the world’s best in radiology

On Oktober 3, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ researcher is among the world’s best in radiology

Alexander Radbruch, a radiologist at the German Cancer Research Center (DKFZ) has been recognized by peer professionals to be among the 15 most influential persons worldwide in the category Radiology Research. Radbruch has become known internationally in recent years from his studies showing that gadolinium, a contrast agent used for…

Heidelberg University: Radioactive Metal Complexes for Tumour Diagnosis and Therapy

On September 14, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Heidelberg University: Radioactive Metal Complexes for Tumour Diagnosis and Therapy

Chemists investigate indium and actinium compounds to develop radiopharmaceuticals Graphics: Miriam Starke, Peter Comba A team under the direction of chemist Prof. Dr Peter Comba is investigating radioactive metal complexes for use in the diagnosis and treatment of tumours. In their recent studies at Heidelberg University’s Institute of Inorganic Chemistry,…

TU Kaiserslautern: 5,4 Millionen Euro jährlich durch die Forschungsinitiative Rheinland-Pfalz

On Juli 13, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für TU Kaiserslautern: 5,4 Millionen Euro jährlich durch die Forschungsinitiative Rheinland-Pfalz

Der rheinland-pfälzische Wissenschaftsminister Konrad Wolf hat heute gemeinsam mit den Präsidenten der Universitäten und Hochschulen des Landes die Zielvereinbarung zur Weiterführung der „Forschungsinitiative Rheinland-Pfalz“ bis 2018 unterzeichnet. Auch die TU Kaiserslautern wird von dieser nächsten Förderphase mit jährlich 5,4 Millionen Euro profitieren. Mit dem Geld soll die Forschung weiter gestärkt…